Valuing the Patient Voice

6 August 2020

By Dr Nicola Davies

As part of its steps to enhance patient engagement, on June 23 2020, the US Food and Drug Administration (FDA) launched Project Patient Voice, a publicly-available website that shares information about patient-reported outcomes (PROs) from cancer clinical trials for marketed treatments.

This pilot project, initiated by the FDA’s Oncology Center of Excellence (OCE), is the first of its kind and will allow insightful PRO data to be more accessible to patients and their healthcare providers. Dr Nicola Davies discusses the increasing value the FDA is placing on the patient voice and how the FDA intends to utilize this voice to inform treatment choices, regulatory decisions, and oncology drug development.

This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Try before you buy

Free

7 day trial access

Take a Free Trial

All the news that moves the needle in pharma and biotech
Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
Receive The Pharma Letter daily news bulletin, free forever.

Become a subscriber

£820

Or £77 per month

Subscribe Now

Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
Daily roundup of key events in pharma and biotech.
Monthly in-depth briefings on Boardroom appointments and M&A news.
Choose from a cost-effective annual package or a flexible monthly subscription

The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK